US Patent Issued to LYELL IMMUNOPHARMA on April 8 for "Codon-optimized nucleotide sequences encoding an AP-1 transcription factor" (Washington, California Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,270,032, issued on April 8, was assigned to LYELL IMMUNOPHARMA INC. (South San Francisco, Calif.).

"Codon-optimized nucleotide sequences encoding an AP-1 transcription factor" was invented by Spencer Park (Seattle), Queenie Vong (South San Francisco, Calif.), Blythe Sather (South San Francisco, Calif.), Byoung Ryu (South San Francisco, Calif.) and Marc Lajoie (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are polynucleotides comprising a nucleotide sequence encoding an AP-1 transcription factor (i.e., c-Jun). In some aspects, the nucleotide sequence is codon-optimized. In some aspects, the polynucleotides co...